ISRG logo

INTUITIVE SURGICAL INC

ISRGNASDAQ
πŸ† #104 by market capEarnings Oct 20 Β· PostUS Equity
$386.98β–Ό $2.21 (βˆ’0.57%)
Simulated price
πŸ””
Track ISRG
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.6%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$146.43B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+20.5%
Healthy
πŸ“ŠGross Margin
66.7%
High
πŸ’΅FCF Margin
29.2%
Strong
βš–οΈP/S Ratio
13.3x
Elevated
Otter Score
76
Good
No chart data available for ISRG.

Trading Snapshot

Day Range
$384.04 – $390.32
52-Week Range
$328.57 – $603.88
Volume
$5.38B
Avg Volume
$6.91B
Shares Outstanding
353.3M
Next Earnings
Nov 16, 2026

Fundamentals Snapshot

Annual Revenue
$10.06B
Last Q Revenue
$2.89B
P/E Ratio
46.8
P/S Ratio
13.3x
EPS (TTM)
$8.85
Dividend Yield
0.00%
Dilution (1yr)
βˆ’1.0%

Why Investors Own ISRG

  • βœ“High-growth profile β€” revenue up +26.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 32% gross margin and 16% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ISRG logo

INTUITIVE SURGICAL INC

ISRG
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$10.1Bβ–² +20.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
66.0%β–Ό βˆ’2.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$2.9Bβ–² +25.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$2.5Bβ–² +91.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
360.4Mβ–Ό βˆ’1.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3.1Bβ–² +$1.2B YoY
StockOtter Β· stockotter.space

About INTUITIVE SURGICAL INC

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
76/100

Analyst Ratings

β“˜
Consensus
Buy
40 analysts
Strong Buy13
Buy16
Hold10
Sell1
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates